1. What Happened? : Analyzing the Treasury Stock Disposal

On September 23, 2025, HLB Biostep announced its decision to dispose of 1,303,067 treasury shares (1.5% of total outstanding shares), equivalent to approximately ₩1.9 billion. The purpose of this disposal is to secure funds through the issuance of convertible bonds.

2. Why This Decision? : Background and Objectives

HLB Biostep has recently faced challenges such as increasing operating losses and low capacity utilization. This decision aims to improve the company’s financial structure by raising capital and securing growth momentum through new business investments and expansions. Convertible bonds offer the advantage of lower interest burdens and potential capital gains through stock conversion upon maturity.

3. What’s Next? : Analyzing the Positive and Negative Impacts

  • Positive Impacts:
    • Improved financial structure and secured growth momentum through fundraising
    • Potential benefits of convertible bond issuance (lower interest burden, potential capital increase)
  • Negative Impacts:
    • Potential stock dilution and increased selling pressure
    • Potential negative impact on investor sentiment if existing fundamental issues (operating losses, low capacity utilization) persist
    • Possible market downturn and negative investor sentiment

4. What Should Investors Do? : Key Checkpoints

Investors should carefully monitor the following factors:

  • Specific plans and progress for the use of the raised funds
  • Efforts to improve profitability and increase capacity utilization in the CRO business
  • Specific growth momentum of new businesses
  • Trends in conversion requests for convertible bonds and their market impact
  • Improvement in financial soundness indicators

HLB Biostep’s treasury stock disposal presents both opportunities and risks. Investors should thoroughly review the key checkpoints outlined above and make informed investment decisions.